Andrew J Murphy

Co-Chief Scientific Officer, Regeneron Pharmaceuticals

Bought, 12 months

$0.0M

Sold, 12 months

$3.2M

Companies

Latest trade

Oct 14, 2026

Companies

Regeneron PharmaceuticalsCo-Chief Scientific Officer −$3.2M

Trades

REGN Sold 4,147 shares at $772.70 · planned $3.2M Oct 14

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.